1h Free Analyst Time
Speak directly to the analyst to clarify any post sales queries you may have.
The cancer early detection market is rapidly transforming healthcare by equipping providers with innovative technologies to improve patient outcomes. Heightened focus on preventive care and early intervention is driving demand for advanced diagnostics, reshaping global oncology practices and investment strategies.
Market Snapshot: Cancer Early Detection Technologies
Global demand for cancer early detection solutions is increasing as healthcare systems prioritize prevention and proactive care pathways. The market’s robust growth reflects uptake of advanced screening, molecular diagnostics, and imaging platforms that offer timely intervention and improved management. High-throughput sequencing, liquid biopsies, and artificial intelligence are central to this evolving landscape. The growing ecosystem includes biotechnology firms, diagnostic laboratories, payers, and policymakers seeking to integrate these innovations into everyday clinical workflows while addressing clinical utility and value-based care requirements.
Scope & Segmentation
This cancer early detection market research report provides in-depth analysis and forecasts across diverse segments and regions:
- Technology: Immunoassay, Mass Spectrometry, Next Generation Sequencing, Polymerase Chain Reaction
- Application: Diagnosis, Monitoring, Prognosis, Screening
- Modality: Biomarker (Epigenetic, Genetic, Protein), Imaging (CT, MRI, PET, Ultrasound), Molecular (Liquid Biopsy, Tissue Biopsy)
- Sample Type: Blood, Saliva, Tissue, Urine
- End User: Ambulatory Surgical Centers, Diagnostic Laboratories, Hospitals, Research Institutes
- Distribution Channel: Direct Sales, Online Platforms, Third Party Distributors
- Regions: Americas (United States: California, Texas, New York, Florida, Illinois, Pennsylvania, Ohio; Canada; Mexico; Brazil; Argentina), Europe, Middle East & Africa (United Kingdom, Germany, France, Russia, Italy, Spain, United Arab Emirates, Saudi Arabia, South Africa, Denmark, Netherlands, Qatar, Finland, Sweden, Nigeria, Egypt, Turkey, Israel, Norway, Poland, Switzerland), Asia-Pacific (China, India, Japan, Australia, South Korea, Indonesia, Thailand, Philippines, Malaysia, Singapore, Vietnam, Taiwan)
- Companies: F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Abbott Laboratories, QIAGEN N.V., Illumina, Inc., Sysmex Corporation, Becton, Dickinson and Company, Bio-Rad Laboratories, Inc., Guardant Health, Inc., Exact Sciences Corporation
Cancer Early Detection Technologies: Key Takeaways
- Collaborations between industry, research, and policymakers accelerate the integration of breakthrough early detection technologies into routine care.
- Molecular diagnostics and AI-powered imaging streamline workflows, enabling earlier diagnosis and more personalized treatment strategies for cancer patients.
- Adoption of decentralized, patient-centric diagnostic models extends access to underserved populations and rural healthcare settings.
- Regulatory agencies facilitate rapid market entry for innovative products through adaptive review processes and evolving guidelines.
- Segment growth is propelled by high adoption rates in leading innovation hubs and expanding public-private partnerships in emerging regions.
Tariff Impact on Cancer Early Detection Technology Supply Chains
Planned United States tariff policies for 2025 are expected to impact procurement costs for critical reagents, equipment, and consumables, prompting manufacturers to adjust sourcing and distribution strategies. Companies are diversifying suppliers and building regional warehouses to reduce supply chain risk. The market also witnesses increased collaboration with domestic manufacturers and advocacy for tariff exemptions to safeguard access to essential early detection tools.
Methodology & Data Sources
Research combines primary data from executive and regulatory interviews with extensive secondary sources, including peer-reviewed literature, patent records, and official industry releases. Analytical frameworks like SWOT and PESTEL, along with scenario modeling and multi-source triangulation, were used to validate findings and provide actionable recommendations for stakeholders.
Why This Report Matters
- Senior decision-makers gain a strategic framework to anticipate technology and policy shifts in the cancer early detection sector.
- Segmented insights enable stakeholders to identify high-potential markets and optimize investments across regions, end uses, and technology categories.
- The report delivers actionable guidance to mitigate supply chain risks and capitalize on emerging diagnostic trends globally.
Conclusion
Cancer early detection continues to reshape preventive healthcare through technology and collaboration. This report supports leaders in navigating evolving dynamics and aligning corporate growth strategies for impact in oncology diagnostics.
This product will be delivered within 1-3 business days.
Table of Contents
1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Integration of liquid biopsy for minimal residual disease monitoring in diverse cancer types
5.2. Adoption of artificial intelligence algorithms for multiomic early cancer detection and risk stratification
5.3. Expansion of at-home sampling kits for colorectal and lung cancer screening in rural populations
5.4. Leveraging machine learning to analyze circulating tumor DNA signatures for early tumor identification
5.5. Commercialization of multi-cancer early detection blood tests with regulatory breakthrough designations
5.6. Development of wearable biosensors for continuous monitoring of cancer-specific biomarker fluctuations
5.7. Partnerships between biotech startups and payers to improve reimbursement for novel screening assays
5.8. Integration of digital pathology and telehealth to enable remote histopathological review and triage
5.2. Adoption of artificial intelligence algorithms for multiomic early cancer detection and risk stratification
5.3. Expansion of at-home sampling kits for colorectal and lung cancer screening in rural populations
5.4. Leveraging machine learning to analyze circulating tumor DNA signatures for early tumor identification
5.5. Commercialization of multi-cancer early detection blood tests with regulatory breakthrough designations
5.6. Development of wearable biosensors for continuous monitoring of cancer-specific biomarker fluctuations
5.7. Partnerships between biotech startups and payers to improve reimbursement for novel screening assays
5.8. Integration of digital pathology and telehealth to enable remote histopathological review and triage
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
6.2. PESTLE Analysis
8. Cancer Early Detection Market, by Technology
8.1. Introduction
8.2. Immunoassay
8.3. Mass Spectrometry
8.4. Next Generation Sequencing
8.5. Polymerase Chain Reaction
8.2. Immunoassay
8.3. Mass Spectrometry
8.4. Next Generation Sequencing
8.5. Polymerase Chain Reaction
9. Cancer Early Detection Market, by Application
9.1. Introduction
9.2. Diagnosis
9.3. Monitoring
9.4. Prognosis
9.5. Screening
9.2. Diagnosis
9.3. Monitoring
9.4. Prognosis
9.5. Screening
10. Cancer Early Detection Market, by Modality
10.1. Introduction
10.2. Biomarker
10.2.1. Epigenetic Biomarker
10.2.2. Genetic Biomarker
10.2.2.1. Dna Methylation
10.2.2.2. Dna Mutation
10.2.2.3. Microrna
10.2.3. Protein Biomarker
10.3. Imaging
10.3.1. Ct
10.3.2. Mri
10.3.3. Pet
10.3.4. Ultrasound
10.4. Molecular
10.4.1. Liquid Biopsy
10.4.2. Tissue Biopsy
10.2. Biomarker
10.2.1. Epigenetic Biomarker
10.2.2. Genetic Biomarker
10.2.2.1. Dna Methylation
10.2.2.2. Dna Mutation
10.2.2.3. Microrna
10.2.3. Protein Biomarker
10.3. Imaging
10.3.1. Ct
10.3.2. Mri
10.3.3. Pet
10.3.4. Ultrasound
10.4. Molecular
10.4.1. Liquid Biopsy
10.4.2. Tissue Biopsy
11. Cancer Early Detection Market, by Sample Type
11.1. Introduction
11.2. Blood
11.3. Saliva
11.4. Tissue
11.5. Urine
11.2. Blood
11.3. Saliva
11.4. Tissue
11.5. Urine
12. Cancer Early Detection Market, by End User
12.1. Introduction
12.2. Ambulatory Surgical Centers
12.3. Diagnostic Laboratories
12.4. Hospitals
12.5. Research Institutes
12.2. Ambulatory Surgical Centers
12.3. Diagnostic Laboratories
12.4. Hospitals
12.5. Research Institutes
13. Cancer Early Detection Market, by Distribution Channel
13.1. Introduction
13.2. Direct Sales
13.3. Online Platforms
13.4. Third Party Distributors
13.2. Direct Sales
13.3. Online Platforms
13.4. Third Party Distributors
14. Americas Cancer Early Detection Market
14.1. Introduction
14.2. United States
14.3. Canada
14.4. Mexico
14.5. Brazil
14.6. Argentina
14.2. United States
14.3. Canada
14.4. Mexico
14.5. Brazil
14.6. Argentina
15. Europe, Middle East & Africa Cancer Early Detection Market
15.1. Introduction
15.2. United Kingdom
15.3. Germany
15.4. France
15.5. Russia
15.6. Italy
15.7. Spain
15.8. United Arab Emirates
15.9. Saudi Arabia
15.10. South Africa
15.11. Denmark
15.12. Netherlands
15.13. Qatar
15.14. Finland
15.15. Sweden
15.16. Nigeria
15.17. Egypt
15.18. Turkey
15.19. Israel
15.20. Norway
15.21. Poland
15.22. Switzerland
15.2. United Kingdom
15.3. Germany
15.4. France
15.5. Russia
15.6. Italy
15.7. Spain
15.8. United Arab Emirates
15.9. Saudi Arabia
15.10. South Africa
15.11. Denmark
15.12. Netherlands
15.13. Qatar
15.14. Finland
15.15. Sweden
15.16. Nigeria
15.17. Egypt
15.18. Turkey
15.19. Israel
15.20. Norway
15.21. Poland
15.22. Switzerland
16. Asia-Pacific Cancer Early Detection Market
16.1. Introduction
16.2. China
16.3. India
16.4. Japan
16.5. Australia
16.6. South Korea
16.7. Indonesia
16.8. Thailand
16.9. Philippines
16.10. Malaysia
16.11. Singapore
16.12. Vietnam
16.13. Taiwan
16.2. China
16.3. India
16.4. Japan
16.5. Australia
16.6. South Korea
16.7. Indonesia
16.8. Thailand
16.9. Philippines
16.10. Malaysia
16.11. Singapore
16.12. Vietnam
16.13. Taiwan
17. Competitive Landscape
17.1. Market Share Analysis, 2024
17.2. FPNV Positioning Matrix, 2024
17.3. Competitive Analysis
17.3.1. F. Hoffmann-La Roche Ltd.
17.3.2. Thermo Fisher Scientific Inc.
17.3.3. Abbott Laboratories
17.3.4. QIAGEN N.V.
17.3.5. Illumina, Inc.
17.3.6. Sysmex Corporation
17.3.7. Becton, Dickinson and Company
17.3.8. Bio-Rad Laboratories, Inc.
17.3.9. Guardant Health, Inc.
17.3.10. Exact Sciences Corporation
17.2. FPNV Positioning Matrix, 2024
17.3. Competitive Analysis
17.3.1. F. Hoffmann-La Roche Ltd.
17.3.2. Thermo Fisher Scientific Inc.
17.3.3. Abbott Laboratories
17.3.4. QIAGEN N.V.
17.3.5. Illumina, Inc.
17.3.6. Sysmex Corporation
17.3.7. Becton, Dickinson and Company
17.3.8. Bio-Rad Laboratories, Inc.
17.3.9. Guardant Health, Inc.
17.3.10. Exact Sciences Corporation
List of Figures
FIGURE 1. CANCER EARLY DETECTION MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL CANCER EARLY DETECTION MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL CANCER EARLY DETECTION MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL CANCER EARLY DETECTION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL CANCER EARLY DETECTION MARKET SIZE, BY TECHNOLOGY, 2024 VS 2030 (%)
FIGURE 6. GLOBAL CANCER EARLY DETECTION MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL CANCER EARLY DETECTION MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 8. GLOBAL CANCER EARLY DETECTION MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL CANCER EARLY DETECTION MARKET SIZE, BY MODALITY, 2024 VS 2030 (%)
FIGURE 10. GLOBAL CANCER EARLY DETECTION MARKET SIZE, BY MODALITY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL CANCER EARLY DETECTION MARKET SIZE, BY SAMPLE TYPE, 2024 VS 2030 (%)
FIGURE 12. GLOBAL CANCER EARLY DETECTION MARKET SIZE, BY SAMPLE TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL CANCER EARLY DETECTION MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 14. GLOBAL CANCER EARLY DETECTION MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL CANCER EARLY DETECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 16. GLOBAL CANCER EARLY DETECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. AMERICAS CANCER EARLY DETECTION MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. AMERICAS CANCER EARLY DETECTION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. UNITED STATES CANCER EARLY DETECTION MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 20. UNITED STATES CANCER EARLY DETECTION MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA CANCER EARLY DETECTION MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA CANCER EARLY DETECTION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. ASIA-PACIFIC CANCER EARLY DETECTION MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. ASIA-PACIFIC CANCER EARLY DETECTION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. CANCER EARLY DETECTION MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 26. CANCER EARLY DETECTION MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 27. CANCER EARLY DETECTION MARKET: RESEARCHAI
FIGURE 28. CANCER EARLY DETECTION MARKET: RESEARCHSTATISTICS
FIGURE 29. CANCER EARLY DETECTION MARKET: RESEARCHCONTACTS
FIGURE 30. CANCER EARLY DETECTION MARKET: RESEARCHARTICLES
FIGURE 2. GLOBAL CANCER EARLY DETECTION MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL CANCER EARLY DETECTION MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL CANCER EARLY DETECTION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL CANCER EARLY DETECTION MARKET SIZE, BY TECHNOLOGY, 2024 VS 2030 (%)
FIGURE 6. GLOBAL CANCER EARLY DETECTION MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL CANCER EARLY DETECTION MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 8. GLOBAL CANCER EARLY DETECTION MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL CANCER EARLY DETECTION MARKET SIZE, BY MODALITY, 2024 VS 2030 (%)
FIGURE 10. GLOBAL CANCER EARLY DETECTION MARKET SIZE, BY MODALITY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL CANCER EARLY DETECTION MARKET SIZE, BY SAMPLE TYPE, 2024 VS 2030 (%)
FIGURE 12. GLOBAL CANCER EARLY DETECTION MARKET SIZE, BY SAMPLE TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL CANCER EARLY DETECTION MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 14. GLOBAL CANCER EARLY DETECTION MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL CANCER EARLY DETECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 16. GLOBAL CANCER EARLY DETECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. AMERICAS CANCER EARLY DETECTION MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. AMERICAS CANCER EARLY DETECTION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. UNITED STATES CANCER EARLY DETECTION MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 20. UNITED STATES CANCER EARLY DETECTION MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA CANCER EARLY DETECTION MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA CANCER EARLY DETECTION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. ASIA-PACIFIC CANCER EARLY DETECTION MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. ASIA-PACIFIC CANCER EARLY DETECTION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. CANCER EARLY DETECTION MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 26. CANCER EARLY DETECTION MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 27. CANCER EARLY DETECTION MARKET: RESEARCHAI
FIGURE 28. CANCER EARLY DETECTION MARKET: RESEARCHSTATISTICS
FIGURE 29. CANCER EARLY DETECTION MARKET: RESEARCHCONTACTS
FIGURE 30. CANCER EARLY DETECTION MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. CANCER EARLY DETECTION MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL CANCER EARLY DETECTION MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL CANCER EARLY DETECTION MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL CANCER EARLY DETECTION MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL CANCER EARLY DETECTION MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL CANCER EARLY DETECTION MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL CANCER EARLY DETECTION MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL CANCER EARLY DETECTION MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL CANCER EARLY DETECTION MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL CANCER EARLY DETECTION MARKET SIZE, BY IMMUNOASSAY, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL CANCER EARLY DETECTION MARKET SIZE, BY IMMUNOASSAY, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL CANCER EARLY DETECTION MARKET SIZE, BY MASS SPECTROMETRY, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL CANCER EARLY DETECTION MARKET SIZE, BY MASS SPECTROMETRY, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL CANCER EARLY DETECTION MARKET SIZE, BY NEXT GENERATION SEQUENCING, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL CANCER EARLY DETECTION MARKET SIZE, BY NEXT GENERATION SEQUENCING, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL CANCER EARLY DETECTION MARKET SIZE, BY POLYMERASE CHAIN REACTION, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL CANCER EARLY DETECTION MARKET SIZE, BY POLYMERASE CHAIN REACTION, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL CANCER EARLY DETECTION MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL CANCER EARLY DETECTION MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL CANCER EARLY DETECTION MARKET SIZE, BY DIAGNOSIS, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL CANCER EARLY DETECTION MARKET SIZE, BY DIAGNOSIS, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL CANCER EARLY DETECTION MARKET SIZE, BY MONITORING, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL CANCER EARLY DETECTION MARKET SIZE, BY MONITORING, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL CANCER EARLY DETECTION MARKET SIZE, BY PROGNOSIS, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL CANCER EARLY DETECTION MARKET SIZE, BY PROGNOSIS, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL CANCER EARLY DETECTION MARKET SIZE, BY SCREENING, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL CANCER EARLY DETECTION MARKET SIZE, BY SCREENING, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL CANCER EARLY DETECTION MARKET SIZE, BY MODALITY, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL CANCER EARLY DETECTION MARKET SIZE, BY MODALITY, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL CANCER EARLY DETECTION MARKET SIZE, BY BIOMARKER, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL CANCER EARLY DETECTION MARKET SIZE, BY BIOMARKER, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL CANCER EARLY DETECTION MARKET SIZE, BY EPIGENETIC BIOMARKER, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL CANCER EARLY DETECTION MARKET SIZE, BY EPIGENETIC BIOMARKER, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL CANCER EARLY DETECTION MARKET SIZE, BY GENETIC BIOMARKER, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL CANCER EARLY DETECTION MARKET SIZE, BY GENETIC BIOMARKER, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL CANCER EARLY DETECTION MARKET SIZE, BY DNA METHYLATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL CANCER EARLY DETECTION MARKET SIZE, BY DNA METHYLATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL CANCER EARLY DETECTION MARKET SIZE, BY DNA MUTATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL CANCER EARLY DETECTION MARKET SIZE, BY DNA MUTATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL CANCER EARLY DETECTION MARKET SIZE, BY MICRORNA, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL CANCER EARLY DETECTION MARKET SIZE, BY MICRORNA, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL CANCER EARLY DETECTION MARKET SIZE, BY GENETIC BIOMARKER, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL CANCER EARLY DETECTION MARKET SIZE, BY GENETIC BIOMARKER, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL CANCER EARLY DETECTION MARKET SIZE, BY PROTEIN BIOMARKER, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL CANCER EARLY DETECTION MARKET SIZE, BY PROTEIN BIOMARKER, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL CANCER EARLY DETECTION MARKET SIZE, BY BIOMARKER, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL CANCER EARLY DETECTION MARKET SIZE, BY BIOMARKER, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL CANCER EARLY DETECTION MARKET SIZE, BY IMAGING, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL CANCER EARLY DETECTION MARKET SIZE, BY IMAGING, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL CANCER EARLY DETECTION MARKET SIZE, BY CT, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL CANCER EARLY DETECTION MARKET SIZE, BY CT, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL CANCER EARLY DETECTION MARKET SIZE, BY MRI, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL CANCER EARLY DETECTION MARKET SIZE, BY MRI, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL CANCER EARLY DETECTION MARKET SIZE, BY PET, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL CANCER EARLY DETECTION MARKET SIZE, BY PET, BY REGION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL CANCER EARLY DETECTION MARKET SIZE, BY ULTRASOUND, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL CANCER EARLY DETECTION MARKET SIZE, BY ULTRASOUND, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL CANCER EARLY DETECTION MARKET SIZE, BY IMAGING, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL CANCER EARLY DETECTION MARKET SIZE, BY IMAGING, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL CANCER EARLY DETECTION MARKET SIZE, BY MOLECULAR, BY REGION, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL CANCER EARLY DETECTION MARKET SIZE, BY MOLECULAR, BY REGION, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL CANCER EARLY DETECTION MARKET SIZE, BY LIQUID BIOPSY, BY REGION, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL CANCER EARLY DETECTION MARKET SIZE, BY LIQUID BIOPSY, BY REGION, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL CANCER EARLY DETECTION MARKET SIZE, BY TISSUE BIOPSY, BY REGION, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL CANCER EARLY DETECTION MARKET SIZE, BY TISSUE BIOPSY, BY REGION, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL CANCER EARLY DETECTION MARKET SIZE, BY MOLECULAR, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL CANCER EARLY DETECTION MARKET SIZE, BY MOLECULAR, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL CANCER EARLY DETECTION MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL CANCER EARLY DETECTION MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL CANCER EARLY DETECTION MARKET SIZE, BY BLOOD, BY REGION, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL CANCER EARLY DETECTION MARKET SIZE, BY BLOOD, BY REGION, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL CANCER EARLY DETECTION MARKET SIZE, BY SALIVA, BY REGION, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL CANCER EARLY DETECTION MARKET SIZE, BY SALIVA, BY REGION, 2025-2030 (USD MILLION)
TABLE 75. GLOBAL CANCER EARLY DETECTION MARKET SIZE, BY TISSUE, BY REGION, 2018-2024 (USD MILLION)
TABLE 76. GLOBAL CANCER EARLY DETECTION MARKET SIZE, BY TISSUE, BY REGION, 2025-2030 (USD MILLION)
TABLE 77. GLOBAL CANCER EARLY DETECTION MARKET SIZE, BY URINE, BY REGION, 2018-2024 (USD MILLION)
TABLE 78. GLOBAL CANCER EARLY DETECTION MARKET SIZE, BY URINE, BY REGION, 2025-2030 (USD MILLION)
TABLE 79. GLOBAL CANCER EARLY DETECTION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 80. GLOBAL CANCER EARLY DETECTION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 81. GLOBAL CANCER EARLY DETECTION MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 82. GLOBAL CANCER EARLY DETECTION MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 83. GLOBAL CANCER EARLY DETECTION MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 84. GLOBAL CANCER EARLY DETECTION MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 85. GLOBAL CANCER EARLY DETECTION MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 86. GLOBAL CANCER EARLY DETECTION MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 87. GLOBAL CANCER EARLY DETECTION MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2024 (USD MILLION)
TABLE 88. GLOBAL CANCER EARLY DETECTION MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2025-2030 (USD MILLION)
TABLE 89. GLOBAL CANCER EARLY DETECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 90. GLOBAL CANCER EARLY DETECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 91. GLOBAL CANCER EARLY DETECTION MARKET SIZE, BY DIRECT SALES, BY REGION, 2018-2024 (USD MILLION)
TABLE 92. GLOBAL CANCER EARLY DETECTION MARKET SIZE, BY DIRECT SALES, BY REGION, 2025-2030 (USD MILLION)
TABLE 93. GLOBAL CANCER EARLY DETECTION MARKET SIZE, BY ONLINE PLATFORMS, BY REGION, 2018-2024 (USD MILLION)
TABLE 94. GLOBAL CANCER EARLY DETECTION MARKET SIZE, BY ONLINE PLATFORMS, BY REGION, 2025-2030 (USD MILLION)
TABLE 95. GLOBAL CANCER EARLY DETECTION MARKET SIZE, BY THIRD PARTY DISTRIBUTORS, BY REGION, 2018-2024 (USD MILLION)
TABLE 96. GLOBAL CANCER EARLY DETECTION MARKET SIZE, BY THIRD PARTY DISTRIBUTORS, BY REGION, 2025-2030 (USD MILLION)
TABLE 97. AMERICAS CANCER EARLY DETECTION MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 98. AMERICAS CANCER EARLY DETECTION MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 99. AMERICAS CANCER EARLY DETECTION MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 100. AMERICAS CANCER EARLY DETECTION MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 101. AMERICAS CANCER EARLY DETECTION MARKET SIZE, BY MODALITY, 2018-2024 (USD MILLION)
TABLE 102. AMERICAS CANCER EARLY DETECTION MARKET SIZE, BY MODALITY, 2025-2030 (USD MILLION)
TABLE 103. AMERICAS CANCER EARLY DETECTION MARKET SIZE, BY BIOMARKER, 2018-2024 (USD MILLION)
TABLE 104. AMERICAS CANCER EARLY DETECTION MARKET SIZE, BY BIOMARKER, 2025-2030 (USD MILLION)
TABLE 105. AMERICAS CANCER EARLY DETECTION MARKET SIZE, BY GENETIC BIOMARKER, 2018-2024 (USD MILLION)
TABLE 106. AMERICAS CANCER EARLY DETECTION MARKET SIZE, BY GENETIC BIOMARKER, 2025-2030 (USD MILLION)
TABLE 107. AMERICAS CANCER EARLY DETECTION MARKET SIZE, BY IMAGING, 2018-2024 (USD MILLION)
TABLE 108. AMERICAS CANCER EARLY DETECTION MARKET SIZE, BY IMAGING, 2025-2030 (USD MILLION)
TABLE 109. AMERICAS CANCER EARLY DETECTION MARKET SIZE, BY MOLECULAR, 2018-2024 (USD MILLION)
TABLE 110. AMERICAS CANCER EARLY DETECTION MARKET SIZE, BY MOLECULAR, 2025-2030 (USD MILLION)
TABLE 111. AMERICAS CANCER EARLY DETECTION MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 112. AMERICAS CANCER EARLY DETECTION MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 113. AMERICAS CANCER EARLY DETECTION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 114. AMERICAS CANCER EARLY DETECTION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 115. AMERICAS CANCER EARLY DETECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 116. AMERICAS CANCER EARLY DETECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 117. AMERICAS CANCER EARLY DETECTION MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 118. AMERICAS CANCER EARLY DETECTION MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 119. UNITED STATES CANCER EARLY DETECTION MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 120. UNITED STATES CANCER EARLY DETECTION MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 121. UNITED STATES CANCER EARLY DETECTION MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 122. UNITED STATES CANCER EARLY DETECTION MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 123. UNITED STATES CANCER EARLY DETECTION MARKET SIZE, BY MODALITY, 2018-2024 (USD MILLION)
TABLE 124. UNITED STATES CANCER EARLY DETECTION MARKET SIZE, BY MODALITY, 2025-2030 (USD MILLION)
TABLE 125. UNITED STATES CANCER EARLY DETECTION MARKET SIZE, BY BIOMARKER, 2018-2024 (USD MILLION)
TABLE 126. UNITED STATES CANCER EARLY DETECTION MARKET SIZE, BY BIOMARKER, 2025-2030 (USD MILLION)
TABLE 127. UNITED STATES CANCER EARLY DETECTION MARKET SIZE, BY GENETIC BIOMARKER, 2018-2024 (USD MILLION)
TABLE 128. UNITED STATES CANCER EARLY DETECTION MARKET SIZE, BY GENETIC BIOMARKER, 2025-2030 (USD MILLION)
TABLE 129. UNITED STATES CANCER EARLY DETECTION MARKET SIZE, BY IMAGING, 2018-2024 (USD MILLION)
TABLE 130. UNITED STATES CANCER EARLY DETECTION MARKET SIZE, BY IMAGING, 2025-2030 (USD MILLION)
TABLE 131. UNITED STATES CANCER EARLY DETECTION MARKET SIZE, BY MOLECULAR, 2018-2024 (USD MILLION)
TABLE 132. UNITED STATES CANCER EARLY DETECTION MARKET SIZE, BY MOLECULAR, 2025-2030 (USD MILLION)
TABLE 133. UNITED STATES CANCER EARLY DETECTION MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 134. UNITED STATES CANCER EARLY DETECTION MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 135. UNITED STATES CANCER EARLY DETECTION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 136. UNITED STATES CANCER EARLY DETECTION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 137. UNITED STATES CANCER EARLY DETECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 138. UNITED STATES CANCER EARLY DETECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 139. UNITED STATES CANCER EARLY DETECTION MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 140. UNITED STATES CANCER EARLY DETECTION MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 141. CANADA CANCER EARLY DETECTION MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 142. CANADA CANCER EARLY DETECTION MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 143. CANADA CANCER EARLY DETECTION MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 144. CANADA CANCER EARLY DETECTION MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 145. CANADA CANCER EARLY DETECTION MARKET SIZE, BY MODALITY, 2018-2024 (USD MILLION)
TABLE 146. CANADA CANCER EARLY DETECTION MARKET SIZE, BY MODALITY, 2025-2030 (USD MILLION)
TABLE 147. CANADA CANCER EARLY DETECTION MARKET SIZE, BY BIOMARKER, 2018-2024 (USD MILLION)
TABLE 148. CANADA CANCER EARLY DETECTION MARKET SIZE, BY BIOMARKER, 2025-2030 (USD MILLION)
TABLE 149. CANADA CANCER EARLY DETECTION MARKET SIZE, BY GENETIC BIOMARKER, 2018-2024 (USD MILLION)
TABLE 150. CANADA CANCER EARLY DETECTION MARKET SIZE, BY GENETIC BIOMARKER, 2025-2030 (USD MILLION)
TABLE 151. CANADA CANCER EARLY DETECTION MARKET SIZE, BY IMAGING, 2018-2024 (USD MILLION)
TABLE 152. CANADA CANCER EARLY DETECTION MARKET SIZE, BY IMAGING, 2025-2030 (USD MILLION)
TABLE 153. CANADA CANCER EARLY DETECTION MARKET SIZE, BY MOLECULAR, 2018-2024 (USD MILLION)
TABLE 154. CANADA CANCER EARLY DETECTION MARKET SIZE, BY MOLECULAR, 2025-2030 (USD MILLION)
TABLE 155. CANADA CANCER EARLY DETECTION MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 156. CANADA CANCER EARLY DETECTION MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 157. CANADA CANCER EARLY DETECTION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 158. CANADA CANCER EARLY DETECTION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 159. CANADA CANCER EARLY DETECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 160. CANADA CANCER EARLY DETECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 161. MEXICO CANCER EARLY DETECTION MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 162. MEXICO CANCER EARLY DETECTION MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 163. MEXICO CANCER EARLY DETECTION MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 164. MEXICO CANCER EARLY DETECTION MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 165. MEXICO CANCER EARLY DETECTION MARKET SIZE, BY MODALITY, 2018-2024 (USD MILLION)
TABLE 166. MEXICO CANCER EARLY DETECTION MARKET SIZE, BY MODALITY, 2025-2030 (USD MILLION)
TABLE 167. MEXICO CANCER EARLY DETECTION MARKET SIZE, BY BIOMARKER, 2018-2024 (USD MILLION)
TABLE 168. MEXICO CANCER EARLY DETECTION MARKET SIZE, BY BIOMARKER, 2025-2030 (USD MILLION)
TABLE 169. MEXICO CANCER EARLY DETECTION MARKET SIZE, BY GENETIC BIOMARKER, 2018-2024 (USD MILLION)
TABLE 170. MEXICO CANCER EARLY DETECTION MARKET SIZE, BY GENETIC BIOMARKER, 2025-2030 (USD MILLION)
TABLE 171. MEXICO CANCER EARLY DETECTION MARKET SIZE, BY IMAGING, 2018-2024 (USD MILLION)
TABLE 172. MEXICO CANCER EARLY DETECTION MARKET SIZE, BY IMAGING, 2025-2030 (USD MILLION)
TABLE 173. MEXICO CANCER EARLY DETECTION MARKET SIZE, BY MOLECULAR, 2018-2024 (USD MILLION)
TABLE 174. MEXICO CANCER EARLY DETECTION MARKET SIZE, BY MOLECULAR, 2025-2030 (USD MILLION)
TABLE 175. MEXICO CANCER EARLY DETECTION MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 176. MEXICO CANCER EARLY DETECTION MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 177. MEXICO CANCER EARLY DETECTION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 178. MEXICO CANCER EARLY DETECTION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 179. MEXICO CANCER EARLY DETECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 180. MEXICO CANCER EARLY DETECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 181. BRAZIL CANCER EARLY DETECTION MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 182. BRAZIL CANCER EARLY DETECTION MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 183. BRAZIL CANCER EARLY DETECTION MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 184. BRAZIL CANCER EARLY DETECTION MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 185. BRAZIL CANCER EARLY DETECTION MARKET SIZE, BY MODALITY, 2018-2024 (USD MILLION)
TABLE 186. BRAZIL CANCER EARLY DETECTION MARKET SIZE, BY MODALITY, 2025-2030 (USD MILLION)
TABLE 187. BRAZIL CANCER EARLY DETECTION MARKET SIZE, BY BIOMARKER, 2018-2024 (USD MILLION)
TABLE 188. BRAZIL CANCER EARLY DETECTION MARKET SIZE, BY BIOMARKER, 2025-2030 (USD MILLION)
TABLE 189. BRAZIL CANCER EARLY DETECTION MARKET SIZE, BY GENETIC BIOMARKER, 2018-2024 (USD MILLION)
TABLE 190. BRAZIL CANCER EARLY DETECTION MARKET SIZE, BY GENETIC BIOMARKER, 2025-2030 (USD MILLION)
TABLE 191. BRAZIL CANCER EARLY DETECTION MARKET SIZE, BY IMAGING, 2018-2024 (USD MILLION)
TABLE 192. BRAZIL CANCER EARLY DETECTION MARKET SIZE, BY IMAGING, 2025-2030 (USD MILLION)
TABLE 193. BRAZIL CANCER EARLY DETECTION MARKET SIZE, BY MOLECULAR, 2018-2024 (USD MILLION)
TABLE 194. BRAZIL CANCER EARLY DETECTION MARKET SIZE, BY MOLECULAR, 2025-2030 (USD MILLION)
TABLE 195. BRAZIL CANCER EARLY DETECTION MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 196. BRAZIL CANCER EARLY DETECTION MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 197. BRAZIL CANCER EARLY DETECTION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 198. BRAZIL CANCER EARLY DETECTION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 199. BRAZIL CANCER EARLY DETECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 200. BRAZIL CANCER EARLY DETECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 201. ARGENTINA CANCER EARLY DETECTION MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 202. ARGENTINA CANCER EARLY DETECTION MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 203. ARGENTINA CANCER EARLY DETECTION MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 204. ARGENTINA CANCER EARLY DETECTION MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 205. ARGENTINA CANCER EARLY DETECTION MARKET SIZE, BY MODALITY, 2018-2024 (USD MILLION)
TABLE 206. ARGENTINA CANCER EARLY DETECTION MARKET SIZE, BY MODALITY, 2025-2030 (USD MILLION)
TABLE 207. ARGENTINA CANCER EARLY DETECTION MARKET SIZE, BY BIOMARKER, 2018-2024 (USD MILLION)
TABLE 208. ARGENTINA CANCER EARLY DETECTION MARKET SIZE, BY BIOMARKER, 2025-2030 (USD MILLION)
TABLE 209. ARGENTINA CANCER EARLY DETECTION MARKET SIZE, BY GENETIC BIOMARKER, 2018-2024 (USD MILLION)
TABLE 210. ARGENTINA CANCER EARLY DETECTION MARKET SIZE, BY GENETIC BIOMARKER, 2025-2030 (USD MILLION)
TABLE 211. ARGENTINA CANCER EARLY DETECTION MARKET SIZE, BY IMAGING, 2018-2024 (USD MILLION)
TABLE 212. ARGENTINA CANCER EARLY DETECTION MARKET SIZE, BY IMAGING, 2025-2030 (USD MILLION)
TABLE 213. ARGENTINA CANCER EARLY DETECTION MARKET SIZE, BY MOLECULAR, 2018-2024 (USD MILLION)
TABLE 214. ARGENTINA CANCER EARLY DETECTION MARKET SIZE, BY MOLECULAR, 2025-2030 (USD MILLION)
TABLE 215. ARGENTINA CANCER EARLY DETECTION MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 216. ARGENTINA CANCER EARLY DETECTION MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 217. ARGENTINA CANCER EARLY DETECTION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 218. ARGENTINA CANCER EARLY DETECTION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 219. ARGENTINA CANCER EARLY DETECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 220. ARGENTINA CANCER EARLY DETECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 221. EUROPE, MIDDLE EAST & AFRICA CANCER EARLY DETECTION MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 222. EUROPE, MIDDLE EAST & AFRICA CANCER EARLY DETECTION MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 223. EUROPE, MIDDLE EAST & AFRICA CANCER EARLY DETECTION MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 224. EUROPE, MIDDLE EAST & AFRICA CANCER EARLY DETECTION MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 225. EUROPE, MIDDLE EAST & AFRICA CANCER EARLY DETECTION MARKET SIZE, BY MODALITY, 2018-2024 (USD MILLION)
TABLE 226. EUROPE, MIDDLE EAST & AFRICA CANCER EARLY DETECTION MARKET SIZE, BY MODALITY, 2025-2030 (USD MILLION)
TABLE 227. EUROPE, MIDDLE EAST & AFRICA CANCER EARLY DETECTION MARKET SIZE, BY BIOMARKER, 2018-2024 (USD MILLION)
TABLE 228. EUROPE, MIDDLE EAST & AFRICA CANCER EARLY DETECTION MARKET SIZE, BY BIOMARKER, 2025-2030 (USD MILLION)
TABLE 229. EUROPE, MIDDLE EAST & AFRICA CANCER EARLY DETECTION MARKET SIZE, BY GENETIC BIOMARKER, 2018-2024 (USD MILLION)
TABLE 230. EUROPE, MIDDLE EAST & AFRICA CANCER EARLY DETECTION MARKET SIZE, BY GENETIC BIOMARKER, 2025-2030 (USD MILLION)
TABLE 231. EUROPE, MIDDLE EAST & AFRICA CANCER EARLY DETECTION MARKET SIZE, BY IMAGING, 2018-2024 (USD MILLION)
TABLE 232. EUROPE, MIDDLE EAST & AFRICA CANCER EARLY DETECTION MARKET SIZE, BY IMAGING, 2025-2030 (USD MILLION)
TABLE 233. EUROPE, MIDDLE EAST & AFRICA CANCER EARLY DETECTION MARKET SIZE, BY MOLECULAR, 2018-2024 (USD MILLION)
TABLE 234. EUROPE, MIDDLE EAST & AFRICA CANCER EARLY DETECTION MARKET SIZE, BY MOLECULAR, 2025-2030 (USD MILLION)
TABLE 235. EUROPE, MIDDLE EAST & AFRICA CANCER EARLY DETECTION MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 236. EUROPE, MIDDLE EAST & AFRICA CANCER EARLY DETECTION MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 237. EUROPE, MIDDLE EAST & AFRICA CANCER EARLY DETECTION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 238. EUROPE, MIDDLE EAST & AFRICA CANCER EARLY DETECTION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 239. EUROPE, MIDDLE EAST & AFRICA CANCER EARLY DETECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 240. EUROPE, MIDDLE EAST & AFRICA CANCER EARLY DETECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 241. EUROPE, MIDDLE EAST & AFRICA CANCER EARLY DETECTION MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 242. EUROPE, MIDDLE EAST & AFRICA CANCER EARLY DETECTION MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 243. UNITED KINGDOM CANCER EARLY DETECTION MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 244. UNITED KINGDOM CANCER EARLY DETECTION MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 245. UNITED KINGDOM CANCER EARLY DETECTION MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 246. UNITED KINGDOM CANCER EARLY DETECTION MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 247. UNITED KINGDOM CANCER EARLY DETECTION MARKET SIZE, BY MODALITY, 2018-2024 (USD MILLION)
TABLE 248. UNITED KINGDOM CANCER EARLY DETECTION MARKET SIZE, BY MODALITY, 2025-2030 (USD MILLION)
TABLE 249. UNITED KINGDOM CANCER EARLY DETECTION MARKET SIZE, BY BIOMARKER, 2018-2024 (USD MILLION)
TABLE 250. UNITED KINGDOM CANCER EARLY DETECTION MARKET SIZE, BY BIOMARKER, 2025-2030 (USD MILLION)
TABLE 251. UNITED KINGDOM CANCER EARLY DETECTION MARKET SIZE, BY GENETIC BIOMARKER, 2018-2024 (USD MILLION)
TABLE 252. UNITED KINGDOM CANCER EARLY DETECTION MARKET SIZE, BY GENETIC BIOMARKER, 2025-2030 (USD MILLION)
TABLE 253. UNITED KINGDOM CANCER EARLY DETECTION MARKET SIZE, BY IMAGING, 2018-2024 (USD MILLION)
TABLE 254. UNITED KINGDOM CANCER EARLY DETECTION MARKET SIZE, BY IMAGING, 2025-2030 (USD MILLION)
TABLE 255. UNITED KINGDOM CANCER EARLY DETECTION MARKET SIZE, BY MOLECULAR, 2018-2024 (USD MILLION)
TABLE 256. UNITED KINGDOM CANCER EARLY DETECTION MARKET SIZE, BY MOLECULAR, 2025-2030 (USD MILLION)
TABLE 257. UNITED KINGDOM CANCER EARLY DETECTION MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 258. UNITED KINGDOM CANCER EARLY DETECTION MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 259. UNITED KINGDOM CANCER EARLY DETECTION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 260. UNITED KINGDOM CANCER EARLY DETECTION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 261. UNITED KINGDOM CANCER EARLY DETECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 262. UNITED KINGDOM CANCER EARLY DETECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 263. GERMANY CANCER EARLY DETECTION MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 264. GERMANY CANCER EARLY DETECTION MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 265. GERMANY CANCER EARLY DETECTION MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 266. GERMANY CANCER EARLY DETECTION MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 267. GERMANY CANCER EARLY DETECTION MARKET SIZE, BY MODALITY, 2018-2024 (USD MILLION)
TABLE 268. GERMANY CANCER EARLY DETECTION MARKET SIZE, BY MODALITY, 2025-2030 (USD MILLION)
TABLE 269. GERMANY CANCER EARLY DETECTION MARKET SIZE, BY BIOMARKER, 2018-2024 (USD MILLION)
TABLE 270. GERMANY CANCER EARLY DETECTION MARKET SIZE, BY BIOMARKER, 2025-2030 (USD MILLION)
TABLE 271. GERMANY CANCER EARLY DETECTION MARKET SIZE, BY GENETIC BIOMARKER, 2018-2024 (USD MILLION)
TABLE 272. GERMANY CANCER EARLY DETECTION MARKET SIZE, BY GENETIC BIOMARKER, 2025-2030 (USD MILLION)
TABLE 273. GERMANY CANCER EARLY DETECTION MARKET SIZE, BY IMAGING, 2018-2024 (USD MILLION)
TABLE 274. GERMANY CANCER EARLY DETECTION MARKET SIZE, BY IMAGING, 2025-2030 (USD MILLION)
TABLE 275. GERMANY CANCER EARLY DETECTION MARKET SIZE, BY MOLECULAR, 2018-2024 (USD MILLION)
TABLE 276. GERMANY CANCER EARLY DETECTION MARKET SIZE, BY MOLECULAR, 2025-2030 (USD MILLION)
TABLE 277. GERMANY CANCER EARLY DETECTION MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 278. GERMANY CANCER EARLY DETECTION MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 279. GERMANY CANCER EARLY DETECTION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 280. GERMANY CANCER EARLY DETECTION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 281. GERMANY CANCER EARLY DETECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 282. GERMANY CANCER EARLY DETECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 283. FRANCE CANCER EARLY DETECTION MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 284. FRANCE CANCER EARLY DETECTION MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 285. FRANCE CANCER EARLY DETECTION MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 286. FRANCE CANCER EARLY DETECTION MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 287. FRANCE CANCER EARLY DETECTION MARKET SIZE, BY MODALITY, 2018-2024 (USD MILLION)
TABLE 288. FRANCE CANCER EARLY DETECTION MARKET SIZE, BY MODALITY, 2025-2030 (USD MILLION)
TABLE 289. FRANCE CANCER EARLY DETECTION MARKET SIZE, BY BIOMARKER, 2018-2024 (USD MILLION)
TABLE 290. FRANCE CANCER EARLY DETECTION MARKET SIZE, BY BIOMARKER, 2025-2030 (USD MILLION)
TABLE 291. FRANCE CANCER EARLY DETECTION MARKET SIZE, BY GENETIC BIOMARKER, 2018-2024 (USD MILLION)
TABLE 292. FRANCE CANCER EARLY DETECTION MARKET SIZE, BY GENETIC BIOMARKER, 2025-2030 (USD MILLION)
TABLE 293. FRANCE CANCER EARLY DETECTION MARKET SIZE, BY IMAGING, 2018-2024 (USD MILLION)
TABLE 294. FRANCE CANCER EARLY DETECTION MARKET SIZE, BY IMAGING, 2025-2030 (USD MILLION)
TABLE 295. FRANCE CANCER EARLY DETECTION MARKET SIZE, BY MOLECULAR, 2018-2024 (USD MILLION)
TABLE 296. FRANCE CANCER EARLY DETECTION MARKET SIZE, BY MOLECULAR, 2025-2030 (USD MILLION)
TABLE 297. FRANCE CANCER EARLY DETECTION MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 298. FRANCE CANCER EARLY DETECTION MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 299. FRANCE CANCER EARLY DETECTION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 300. FRANCE CANCER EARLY DETECTION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 301. FRANCE CANCER EARLY DETECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 302. FRANCE CANCER EARLY DETECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 303. RUSSIA CANCER EARLY DETECTION MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 304. RUSSIA CANCER EARLY DETECTION MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 305. RUSSIA CANCER EARLY DETECTION MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 306. RUSSIA CANCER EARLY DETECTION MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 307. RUSSIA CANCER EARLY DETECTION MARKET SIZE, BY MODALITY, 2018-2024 (USD MILLION)
TABLE 308. RUSSIA CANCER EARLY DETECTION MARKET SIZE, BY MODALITY, 2025-2030 (USD MILLION)
TABLE 309. RUSSIA CANCER EARLY DETECTION MARKET SIZE, BY BIOMARKER, 2018-2024 (USD MILLION)
TABLE 310. RUSSIA CANCER EARLY DETECTION MARKET SIZE, BY BIOMARKER, 2025-2030 (USD MILLION)
TABLE 311. RUSSIA CANCER EARLY DETECTION MARKET SIZE, BY GENETIC BIOMARKER, 2018-2024 (USD MILLION)
TABLE 312. RUSSIA CANCER EARLY DETECTION MARKET SIZE, BY GENETIC BIOMARKER, 2025-2030 (USD MILLION)
TABLE 313. RUSSIA CANCER EARLY DETECTION MARKET SIZE, BY IMAGING, 2018-2024 (USD MILLION)
TABLE 314. RUSSIA CANCER EARLY DETECTION MARKET SIZE, BY IMAGING, 2025-2030 (USD MILLION)
TABLE 315. RUSSIA CANCER EARLY DETECTION MARKET SIZE, BY MOLECULAR, 2018-2024 (USD MILLION)
TABLE 316. RUSSIA CANCER EARLY DETECTION MARKET SIZE, BY MOLECULAR, 2025-2030 (USD MILLION)
TABLE 317. RUSSIA CANCER EARLY DETECTION MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 318. RUSSIA CANCER EARLY DETECTION MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 319. RUSSIA CANCER EARLY DETECTION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 320. RUSSIA CANCER EARLY DETECTION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 321. RUSSIA CANCER EARLY DETECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 322. RUSSIA CANCER EARLY DETECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 323. ITALY CANCER EARLY DETECTION MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 324. ITALY CANCER EARLY DETECTION MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 325. ITALY CANCER EARLY DETECTION MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 326. ITALY CANCER EARLY DETECTION MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 327. ITALY CANCER EARLY DETECTION MARKET SIZE, BY MODALITY, 2018-2024 (USD MILLION)
TABLE 328. ITALY CANCER EARLY DETECTION MARKET SIZE, BY MODALITY, 2025-2030 (USD MILLION)
TABLE 329. ITALY CANCER EARLY DETECTION MARKET SIZE, BY BIOMARKER, 2018-2024 (USD MILLION)
TABLE 330. ITALY CANCER EARLY DETECTION MARKET SIZE, BY BIOMARKER, 2025-2030 (USD MILLION)
TABLE 331. ITALY CANCER EARLY DETECTION MARKET SIZE, BY GENETIC BIOMARKER, 2018-2024 (USD MILLION)
TABLE 332. ITALY CANCER EARLY DETECTION MARKET SIZE, BY GENETIC BIOMARKER, 2025-2030 (USD MILLION)
TABLE 333. ITALY CANCER EARLY DETECTION MARKE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL CANCER EARLY DETECTION MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL CANCER EARLY DETECTION MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL CANCER EARLY DETECTION MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL CANCER EARLY DETECTION MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL CANCER EARLY DETECTION MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL CANCER EARLY DETECTION MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL CANCER EARLY DETECTION MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL CANCER EARLY DETECTION MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL CANCER EARLY DETECTION MARKET SIZE, BY IMMUNOASSAY, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL CANCER EARLY DETECTION MARKET SIZE, BY IMMUNOASSAY, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL CANCER EARLY DETECTION MARKET SIZE, BY MASS SPECTROMETRY, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL CANCER EARLY DETECTION MARKET SIZE, BY MASS SPECTROMETRY, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL CANCER EARLY DETECTION MARKET SIZE, BY NEXT GENERATION SEQUENCING, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL CANCER EARLY DETECTION MARKET SIZE, BY NEXT GENERATION SEQUENCING, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL CANCER EARLY DETECTION MARKET SIZE, BY POLYMERASE CHAIN REACTION, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL CANCER EARLY DETECTION MARKET SIZE, BY POLYMERASE CHAIN REACTION, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL CANCER EARLY DETECTION MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL CANCER EARLY DETECTION MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL CANCER EARLY DETECTION MARKET SIZE, BY DIAGNOSIS, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL CANCER EARLY DETECTION MARKET SIZE, BY DIAGNOSIS, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL CANCER EARLY DETECTION MARKET SIZE, BY MONITORING, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL CANCER EARLY DETECTION MARKET SIZE, BY MONITORING, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL CANCER EARLY DETECTION MARKET SIZE, BY PROGNOSIS, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL CANCER EARLY DETECTION MARKET SIZE, BY PROGNOSIS, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL CANCER EARLY DETECTION MARKET SIZE, BY SCREENING, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL CANCER EARLY DETECTION MARKET SIZE, BY SCREENING, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL CANCER EARLY DETECTION MARKET SIZE, BY MODALITY, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL CANCER EARLY DETECTION MARKET SIZE, BY MODALITY, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL CANCER EARLY DETECTION MARKET SIZE, BY BIOMARKER, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL CANCER EARLY DETECTION MARKET SIZE, BY BIOMARKER, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL CANCER EARLY DETECTION MARKET SIZE, BY EPIGENETIC BIOMARKER, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL CANCER EARLY DETECTION MARKET SIZE, BY EPIGENETIC BIOMARKER, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL CANCER EARLY DETECTION MARKET SIZE, BY GENETIC BIOMARKER, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL CANCER EARLY DETECTION MARKET SIZE, BY GENETIC BIOMARKER, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL CANCER EARLY DETECTION MARKET SIZE, BY DNA METHYLATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL CANCER EARLY DETECTION MARKET SIZE, BY DNA METHYLATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL CANCER EARLY DETECTION MARKET SIZE, BY DNA MUTATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL CANCER EARLY DETECTION MARKET SIZE, BY DNA MUTATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL CANCER EARLY DETECTION MARKET SIZE, BY MICRORNA, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL CANCER EARLY DETECTION MARKET SIZE, BY MICRORNA, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL CANCER EARLY DETECTION MARKET SIZE, BY GENETIC BIOMARKER, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL CANCER EARLY DETECTION MARKET SIZE, BY GENETIC BIOMARKER, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL CANCER EARLY DETECTION MARKET SIZE, BY PROTEIN BIOMARKER, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL CANCER EARLY DETECTION MARKET SIZE, BY PROTEIN BIOMARKER, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL CANCER EARLY DETECTION MARKET SIZE, BY BIOMARKER, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL CANCER EARLY DETECTION MARKET SIZE, BY BIOMARKER, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL CANCER EARLY DETECTION MARKET SIZE, BY IMAGING, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL CANCER EARLY DETECTION MARKET SIZE, BY IMAGING, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL CANCER EARLY DETECTION MARKET SIZE, BY CT, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL CANCER EARLY DETECTION MARKET SIZE, BY CT, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL CANCER EARLY DETECTION MARKET SIZE, BY MRI, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL CANCER EARLY DETECTION MARKET SIZE, BY MRI, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL CANCER EARLY DETECTION MARKET SIZE, BY PET, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL CANCER EARLY DETECTION MARKET SIZE, BY PET, BY REGION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL CANCER EARLY DETECTION MARKET SIZE, BY ULTRASOUND, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL CANCER EARLY DETECTION MARKET SIZE, BY ULTRASOUND, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL CANCER EARLY DETECTION MARKET SIZE, BY IMAGING, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL CANCER EARLY DETECTION MARKET SIZE, BY IMAGING, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL CANCER EARLY DETECTION MARKET SIZE, BY MOLECULAR, BY REGION, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL CANCER EARLY DETECTION MARKET SIZE, BY MOLECULAR, BY REGION, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL CANCER EARLY DETECTION MARKET SIZE, BY LIQUID BIOPSY, BY REGION, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL CANCER EARLY DETECTION MARKET SIZE, BY LIQUID BIOPSY, BY REGION, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL CANCER EARLY DETECTION MARKET SIZE, BY TISSUE BIOPSY, BY REGION, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL CANCER EARLY DETECTION MARKET SIZE, BY TISSUE BIOPSY, BY REGION, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL CANCER EARLY DETECTION MARKET SIZE, BY MOLECULAR, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL CANCER EARLY DETECTION MARKET SIZE, BY MOLECULAR, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL CANCER EARLY DETECTION MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL CANCER EARLY DETECTION MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL CANCER EARLY DETECTION MARKET SIZE, BY BLOOD, BY REGION, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL CANCER EARLY DETECTION MARKET SIZE, BY BLOOD, BY REGION, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL CANCER EARLY DETECTION MARKET SIZE, BY SALIVA, BY REGION, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL CANCER EARLY DETECTION MARKET SIZE, BY SALIVA, BY REGION, 2025-2030 (USD MILLION)
TABLE 75. GLOBAL CANCER EARLY DETECTION MARKET SIZE, BY TISSUE, BY REGION, 2018-2024 (USD MILLION)
TABLE 76. GLOBAL CANCER EARLY DETECTION MARKET SIZE, BY TISSUE, BY REGION, 2025-2030 (USD MILLION)
TABLE 77. GLOBAL CANCER EARLY DETECTION MARKET SIZE, BY URINE, BY REGION, 2018-2024 (USD MILLION)
TABLE 78. GLOBAL CANCER EARLY DETECTION MARKET SIZE, BY URINE, BY REGION, 2025-2030 (USD MILLION)
TABLE 79. GLOBAL CANCER EARLY DETECTION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 80. GLOBAL CANCER EARLY DETECTION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 81. GLOBAL CANCER EARLY DETECTION MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 82. GLOBAL CANCER EARLY DETECTION MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 83. GLOBAL CANCER EARLY DETECTION MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 84. GLOBAL CANCER EARLY DETECTION MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 85. GLOBAL CANCER EARLY DETECTION MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 86. GLOBAL CANCER EARLY DETECTION MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 87. GLOBAL CANCER EARLY DETECTION MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2024 (USD MILLION)
TABLE 88. GLOBAL CANCER EARLY DETECTION MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2025-2030 (USD MILLION)
TABLE 89. GLOBAL CANCER EARLY DETECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 90. GLOBAL CANCER EARLY DETECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 91. GLOBAL CANCER EARLY DETECTION MARKET SIZE, BY DIRECT SALES, BY REGION, 2018-2024 (USD MILLION)
TABLE 92. GLOBAL CANCER EARLY DETECTION MARKET SIZE, BY DIRECT SALES, BY REGION, 2025-2030 (USD MILLION)
TABLE 93. GLOBAL CANCER EARLY DETECTION MARKET SIZE, BY ONLINE PLATFORMS, BY REGION, 2018-2024 (USD MILLION)
TABLE 94. GLOBAL CANCER EARLY DETECTION MARKET SIZE, BY ONLINE PLATFORMS, BY REGION, 2025-2030 (USD MILLION)
TABLE 95. GLOBAL CANCER EARLY DETECTION MARKET SIZE, BY THIRD PARTY DISTRIBUTORS, BY REGION, 2018-2024 (USD MILLION)
TABLE 96. GLOBAL CANCER EARLY DETECTION MARKET SIZE, BY THIRD PARTY DISTRIBUTORS, BY REGION, 2025-2030 (USD MILLION)
TABLE 97. AMERICAS CANCER EARLY DETECTION MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 98. AMERICAS CANCER EARLY DETECTION MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 99. AMERICAS CANCER EARLY DETECTION MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 100. AMERICAS CANCER EARLY DETECTION MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 101. AMERICAS CANCER EARLY DETECTION MARKET SIZE, BY MODALITY, 2018-2024 (USD MILLION)
TABLE 102. AMERICAS CANCER EARLY DETECTION MARKET SIZE, BY MODALITY, 2025-2030 (USD MILLION)
TABLE 103. AMERICAS CANCER EARLY DETECTION MARKET SIZE, BY BIOMARKER, 2018-2024 (USD MILLION)
TABLE 104. AMERICAS CANCER EARLY DETECTION MARKET SIZE, BY BIOMARKER, 2025-2030 (USD MILLION)
TABLE 105. AMERICAS CANCER EARLY DETECTION MARKET SIZE, BY GENETIC BIOMARKER, 2018-2024 (USD MILLION)
TABLE 106. AMERICAS CANCER EARLY DETECTION MARKET SIZE, BY GENETIC BIOMARKER, 2025-2030 (USD MILLION)
TABLE 107. AMERICAS CANCER EARLY DETECTION MARKET SIZE, BY IMAGING, 2018-2024 (USD MILLION)
TABLE 108. AMERICAS CANCER EARLY DETECTION MARKET SIZE, BY IMAGING, 2025-2030 (USD MILLION)
TABLE 109. AMERICAS CANCER EARLY DETECTION MARKET SIZE, BY MOLECULAR, 2018-2024 (USD MILLION)
TABLE 110. AMERICAS CANCER EARLY DETECTION MARKET SIZE, BY MOLECULAR, 2025-2030 (USD MILLION)
TABLE 111. AMERICAS CANCER EARLY DETECTION MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 112. AMERICAS CANCER EARLY DETECTION MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 113. AMERICAS CANCER EARLY DETECTION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 114. AMERICAS CANCER EARLY DETECTION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 115. AMERICAS CANCER EARLY DETECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 116. AMERICAS CANCER EARLY DETECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 117. AMERICAS CANCER EARLY DETECTION MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 118. AMERICAS CANCER EARLY DETECTION MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 119. UNITED STATES CANCER EARLY DETECTION MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 120. UNITED STATES CANCER EARLY DETECTION MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 121. UNITED STATES CANCER EARLY DETECTION MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 122. UNITED STATES CANCER EARLY DETECTION MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 123. UNITED STATES CANCER EARLY DETECTION MARKET SIZE, BY MODALITY, 2018-2024 (USD MILLION)
TABLE 124. UNITED STATES CANCER EARLY DETECTION MARKET SIZE, BY MODALITY, 2025-2030 (USD MILLION)
TABLE 125. UNITED STATES CANCER EARLY DETECTION MARKET SIZE, BY BIOMARKER, 2018-2024 (USD MILLION)
TABLE 126. UNITED STATES CANCER EARLY DETECTION MARKET SIZE, BY BIOMARKER, 2025-2030 (USD MILLION)
TABLE 127. UNITED STATES CANCER EARLY DETECTION MARKET SIZE, BY GENETIC BIOMARKER, 2018-2024 (USD MILLION)
TABLE 128. UNITED STATES CANCER EARLY DETECTION MARKET SIZE, BY GENETIC BIOMARKER, 2025-2030 (USD MILLION)
TABLE 129. UNITED STATES CANCER EARLY DETECTION MARKET SIZE, BY IMAGING, 2018-2024 (USD MILLION)
TABLE 130. UNITED STATES CANCER EARLY DETECTION MARKET SIZE, BY IMAGING, 2025-2030 (USD MILLION)
TABLE 131. UNITED STATES CANCER EARLY DETECTION MARKET SIZE, BY MOLECULAR, 2018-2024 (USD MILLION)
TABLE 132. UNITED STATES CANCER EARLY DETECTION MARKET SIZE, BY MOLECULAR, 2025-2030 (USD MILLION)
TABLE 133. UNITED STATES CANCER EARLY DETECTION MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 134. UNITED STATES CANCER EARLY DETECTION MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 135. UNITED STATES CANCER EARLY DETECTION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 136. UNITED STATES CANCER EARLY DETECTION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 137. UNITED STATES CANCER EARLY DETECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 138. UNITED STATES CANCER EARLY DETECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 139. UNITED STATES CANCER EARLY DETECTION MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 140. UNITED STATES CANCER EARLY DETECTION MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 141. CANADA CANCER EARLY DETECTION MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 142. CANADA CANCER EARLY DETECTION MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 143. CANADA CANCER EARLY DETECTION MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 144. CANADA CANCER EARLY DETECTION MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 145. CANADA CANCER EARLY DETECTION MARKET SIZE, BY MODALITY, 2018-2024 (USD MILLION)
TABLE 146. CANADA CANCER EARLY DETECTION MARKET SIZE, BY MODALITY, 2025-2030 (USD MILLION)
TABLE 147. CANADA CANCER EARLY DETECTION MARKET SIZE, BY BIOMARKER, 2018-2024 (USD MILLION)
TABLE 148. CANADA CANCER EARLY DETECTION MARKET SIZE, BY BIOMARKER, 2025-2030 (USD MILLION)
TABLE 149. CANADA CANCER EARLY DETECTION MARKET SIZE, BY GENETIC BIOMARKER, 2018-2024 (USD MILLION)
TABLE 150. CANADA CANCER EARLY DETECTION MARKET SIZE, BY GENETIC BIOMARKER, 2025-2030 (USD MILLION)
TABLE 151. CANADA CANCER EARLY DETECTION MARKET SIZE, BY IMAGING, 2018-2024 (USD MILLION)
TABLE 152. CANADA CANCER EARLY DETECTION MARKET SIZE, BY IMAGING, 2025-2030 (USD MILLION)
TABLE 153. CANADA CANCER EARLY DETECTION MARKET SIZE, BY MOLECULAR, 2018-2024 (USD MILLION)
TABLE 154. CANADA CANCER EARLY DETECTION MARKET SIZE, BY MOLECULAR, 2025-2030 (USD MILLION)
TABLE 155. CANADA CANCER EARLY DETECTION MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 156. CANADA CANCER EARLY DETECTION MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 157. CANADA CANCER EARLY DETECTION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 158. CANADA CANCER EARLY DETECTION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 159. CANADA CANCER EARLY DETECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 160. CANADA CANCER EARLY DETECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 161. MEXICO CANCER EARLY DETECTION MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 162. MEXICO CANCER EARLY DETECTION MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 163. MEXICO CANCER EARLY DETECTION MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 164. MEXICO CANCER EARLY DETECTION MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 165. MEXICO CANCER EARLY DETECTION MARKET SIZE, BY MODALITY, 2018-2024 (USD MILLION)
TABLE 166. MEXICO CANCER EARLY DETECTION MARKET SIZE, BY MODALITY, 2025-2030 (USD MILLION)
TABLE 167. MEXICO CANCER EARLY DETECTION MARKET SIZE, BY BIOMARKER, 2018-2024 (USD MILLION)
TABLE 168. MEXICO CANCER EARLY DETECTION MARKET SIZE, BY BIOMARKER, 2025-2030 (USD MILLION)
TABLE 169. MEXICO CANCER EARLY DETECTION MARKET SIZE, BY GENETIC BIOMARKER, 2018-2024 (USD MILLION)
TABLE 170. MEXICO CANCER EARLY DETECTION MARKET SIZE, BY GENETIC BIOMARKER, 2025-2030 (USD MILLION)
TABLE 171. MEXICO CANCER EARLY DETECTION MARKET SIZE, BY IMAGING, 2018-2024 (USD MILLION)
TABLE 172. MEXICO CANCER EARLY DETECTION MARKET SIZE, BY IMAGING, 2025-2030 (USD MILLION)
TABLE 173. MEXICO CANCER EARLY DETECTION MARKET SIZE, BY MOLECULAR, 2018-2024 (USD MILLION)
TABLE 174. MEXICO CANCER EARLY DETECTION MARKET SIZE, BY MOLECULAR, 2025-2030 (USD MILLION)
TABLE 175. MEXICO CANCER EARLY DETECTION MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 176. MEXICO CANCER EARLY DETECTION MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 177. MEXICO CANCER EARLY DETECTION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 178. MEXICO CANCER EARLY DETECTION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 179. MEXICO CANCER EARLY DETECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 180. MEXICO CANCER EARLY DETECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 181. BRAZIL CANCER EARLY DETECTION MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 182. BRAZIL CANCER EARLY DETECTION MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 183. BRAZIL CANCER EARLY DETECTION MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 184. BRAZIL CANCER EARLY DETECTION MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 185. BRAZIL CANCER EARLY DETECTION MARKET SIZE, BY MODALITY, 2018-2024 (USD MILLION)
TABLE 186. BRAZIL CANCER EARLY DETECTION MARKET SIZE, BY MODALITY, 2025-2030 (USD MILLION)
TABLE 187. BRAZIL CANCER EARLY DETECTION MARKET SIZE, BY BIOMARKER, 2018-2024 (USD MILLION)
TABLE 188. BRAZIL CANCER EARLY DETECTION MARKET SIZE, BY BIOMARKER, 2025-2030 (USD MILLION)
TABLE 189. BRAZIL CANCER EARLY DETECTION MARKET SIZE, BY GENETIC BIOMARKER, 2018-2024 (USD MILLION)
TABLE 190. BRAZIL CANCER EARLY DETECTION MARKET SIZE, BY GENETIC BIOMARKER, 2025-2030 (USD MILLION)
TABLE 191. BRAZIL CANCER EARLY DETECTION MARKET SIZE, BY IMAGING, 2018-2024 (USD MILLION)
TABLE 192. BRAZIL CANCER EARLY DETECTION MARKET SIZE, BY IMAGING, 2025-2030 (USD MILLION)
TABLE 193. BRAZIL CANCER EARLY DETECTION MARKET SIZE, BY MOLECULAR, 2018-2024 (USD MILLION)
TABLE 194. BRAZIL CANCER EARLY DETECTION MARKET SIZE, BY MOLECULAR, 2025-2030 (USD MILLION)
TABLE 195. BRAZIL CANCER EARLY DETECTION MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 196. BRAZIL CANCER EARLY DETECTION MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 197. BRAZIL CANCER EARLY DETECTION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 198. BRAZIL CANCER EARLY DETECTION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 199. BRAZIL CANCER EARLY DETECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 200. BRAZIL CANCER EARLY DETECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 201. ARGENTINA CANCER EARLY DETECTION MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 202. ARGENTINA CANCER EARLY DETECTION MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 203. ARGENTINA CANCER EARLY DETECTION MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 204. ARGENTINA CANCER EARLY DETECTION MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 205. ARGENTINA CANCER EARLY DETECTION MARKET SIZE, BY MODALITY, 2018-2024 (USD MILLION)
TABLE 206. ARGENTINA CANCER EARLY DETECTION MARKET SIZE, BY MODALITY, 2025-2030 (USD MILLION)
TABLE 207. ARGENTINA CANCER EARLY DETECTION MARKET SIZE, BY BIOMARKER, 2018-2024 (USD MILLION)
TABLE 208. ARGENTINA CANCER EARLY DETECTION MARKET SIZE, BY BIOMARKER, 2025-2030 (USD MILLION)
TABLE 209. ARGENTINA CANCER EARLY DETECTION MARKET SIZE, BY GENETIC BIOMARKER, 2018-2024 (USD MILLION)
TABLE 210. ARGENTINA CANCER EARLY DETECTION MARKET SIZE, BY GENETIC BIOMARKER, 2025-2030 (USD MILLION)
TABLE 211. ARGENTINA CANCER EARLY DETECTION MARKET SIZE, BY IMAGING, 2018-2024 (USD MILLION)
TABLE 212. ARGENTINA CANCER EARLY DETECTION MARKET SIZE, BY IMAGING, 2025-2030 (USD MILLION)
TABLE 213. ARGENTINA CANCER EARLY DETECTION MARKET SIZE, BY MOLECULAR, 2018-2024 (USD MILLION)
TABLE 214. ARGENTINA CANCER EARLY DETECTION MARKET SIZE, BY MOLECULAR, 2025-2030 (USD MILLION)
TABLE 215. ARGENTINA CANCER EARLY DETECTION MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 216. ARGENTINA CANCER EARLY DETECTION MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 217. ARGENTINA CANCER EARLY DETECTION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 218. ARGENTINA CANCER EARLY DETECTION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 219. ARGENTINA CANCER EARLY DETECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 220. ARGENTINA CANCER EARLY DETECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 221. EUROPE, MIDDLE EAST & AFRICA CANCER EARLY DETECTION MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 222. EUROPE, MIDDLE EAST & AFRICA CANCER EARLY DETECTION MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 223. EUROPE, MIDDLE EAST & AFRICA CANCER EARLY DETECTION MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 224. EUROPE, MIDDLE EAST & AFRICA CANCER EARLY DETECTION MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 225. EUROPE, MIDDLE EAST & AFRICA CANCER EARLY DETECTION MARKET SIZE, BY MODALITY, 2018-2024 (USD MILLION)
TABLE 226. EUROPE, MIDDLE EAST & AFRICA CANCER EARLY DETECTION MARKET SIZE, BY MODALITY, 2025-2030 (USD MILLION)
TABLE 227. EUROPE, MIDDLE EAST & AFRICA CANCER EARLY DETECTION MARKET SIZE, BY BIOMARKER, 2018-2024 (USD MILLION)
TABLE 228. EUROPE, MIDDLE EAST & AFRICA CANCER EARLY DETECTION MARKET SIZE, BY BIOMARKER, 2025-2030 (USD MILLION)
TABLE 229. EUROPE, MIDDLE EAST & AFRICA CANCER EARLY DETECTION MARKET SIZE, BY GENETIC BIOMARKER, 2018-2024 (USD MILLION)
TABLE 230. EUROPE, MIDDLE EAST & AFRICA CANCER EARLY DETECTION MARKET SIZE, BY GENETIC BIOMARKER, 2025-2030 (USD MILLION)
TABLE 231. EUROPE, MIDDLE EAST & AFRICA CANCER EARLY DETECTION MARKET SIZE, BY IMAGING, 2018-2024 (USD MILLION)
TABLE 232. EUROPE, MIDDLE EAST & AFRICA CANCER EARLY DETECTION MARKET SIZE, BY IMAGING, 2025-2030 (USD MILLION)
TABLE 233. EUROPE, MIDDLE EAST & AFRICA CANCER EARLY DETECTION MARKET SIZE, BY MOLECULAR, 2018-2024 (USD MILLION)
TABLE 234. EUROPE, MIDDLE EAST & AFRICA CANCER EARLY DETECTION MARKET SIZE, BY MOLECULAR, 2025-2030 (USD MILLION)
TABLE 235. EUROPE, MIDDLE EAST & AFRICA CANCER EARLY DETECTION MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 236. EUROPE, MIDDLE EAST & AFRICA CANCER EARLY DETECTION MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 237. EUROPE, MIDDLE EAST & AFRICA CANCER EARLY DETECTION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 238. EUROPE, MIDDLE EAST & AFRICA CANCER EARLY DETECTION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 239. EUROPE, MIDDLE EAST & AFRICA CANCER EARLY DETECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 240. EUROPE, MIDDLE EAST & AFRICA CANCER EARLY DETECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 241. EUROPE, MIDDLE EAST & AFRICA CANCER EARLY DETECTION MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 242. EUROPE, MIDDLE EAST & AFRICA CANCER EARLY DETECTION MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 243. UNITED KINGDOM CANCER EARLY DETECTION MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 244. UNITED KINGDOM CANCER EARLY DETECTION MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 245. UNITED KINGDOM CANCER EARLY DETECTION MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 246. UNITED KINGDOM CANCER EARLY DETECTION MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 247. UNITED KINGDOM CANCER EARLY DETECTION MARKET SIZE, BY MODALITY, 2018-2024 (USD MILLION)
TABLE 248. UNITED KINGDOM CANCER EARLY DETECTION MARKET SIZE, BY MODALITY, 2025-2030 (USD MILLION)
TABLE 249. UNITED KINGDOM CANCER EARLY DETECTION MARKET SIZE, BY BIOMARKER, 2018-2024 (USD MILLION)
TABLE 250. UNITED KINGDOM CANCER EARLY DETECTION MARKET SIZE, BY BIOMARKER, 2025-2030 (USD MILLION)
TABLE 251. UNITED KINGDOM CANCER EARLY DETECTION MARKET SIZE, BY GENETIC BIOMARKER, 2018-2024 (USD MILLION)
TABLE 252. UNITED KINGDOM CANCER EARLY DETECTION MARKET SIZE, BY GENETIC BIOMARKER, 2025-2030 (USD MILLION)
TABLE 253. UNITED KINGDOM CANCER EARLY DETECTION MARKET SIZE, BY IMAGING, 2018-2024 (USD MILLION)
TABLE 254. UNITED KINGDOM CANCER EARLY DETECTION MARKET SIZE, BY IMAGING, 2025-2030 (USD MILLION)
TABLE 255. UNITED KINGDOM CANCER EARLY DETECTION MARKET SIZE, BY MOLECULAR, 2018-2024 (USD MILLION)
TABLE 256. UNITED KINGDOM CANCER EARLY DETECTION MARKET SIZE, BY MOLECULAR, 2025-2030 (USD MILLION)
TABLE 257. UNITED KINGDOM CANCER EARLY DETECTION MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 258. UNITED KINGDOM CANCER EARLY DETECTION MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 259. UNITED KINGDOM CANCER EARLY DETECTION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 260. UNITED KINGDOM CANCER EARLY DETECTION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 261. UNITED KINGDOM CANCER EARLY DETECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 262. UNITED KINGDOM CANCER EARLY DETECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 263. GERMANY CANCER EARLY DETECTION MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 264. GERMANY CANCER EARLY DETECTION MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 265. GERMANY CANCER EARLY DETECTION MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 266. GERMANY CANCER EARLY DETECTION MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 267. GERMANY CANCER EARLY DETECTION MARKET SIZE, BY MODALITY, 2018-2024 (USD MILLION)
TABLE 268. GERMANY CANCER EARLY DETECTION MARKET SIZE, BY MODALITY, 2025-2030 (USD MILLION)
TABLE 269. GERMANY CANCER EARLY DETECTION MARKET SIZE, BY BIOMARKER, 2018-2024 (USD MILLION)
TABLE 270. GERMANY CANCER EARLY DETECTION MARKET SIZE, BY BIOMARKER, 2025-2030 (USD MILLION)
TABLE 271. GERMANY CANCER EARLY DETECTION MARKET SIZE, BY GENETIC BIOMARKER, 2018-2024 (USD MILLION)
TABLE 272. GERMANY CANCER EARLY DETECTION MARKET SIZE, BY GENETIC BIOMARKER, 2025-2030 (USD MILLION)
TABLE 273. GERMANY CANCER EARLY DETECTION MARKET SIZE, BY IMAGING, 2018-2024 (USD MILLION)
TABLE 274. GERMANY CANCER EARLY DETECTION MARKET SIZE, BY IMAGING, 2025-2030 (USD MILLION)
TABLE 275. GERMANY CANCER EARLY DETECTION MARKET SIZE, BY MOLECULAR, 2018-2024 (USD MILLION)
TABLE 276. GERMANY CANCER EARLY DETECTION MARKET SIZE, BY MOLECULAR, 2025-2030 (USD MILLION)
TABLE 277. GERMANY CANCER EARLY DETECTION MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 278. GERMANY CANCER EARLY DETECTION MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 279. GERMANY CANCER EARLY DETECTION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 280. GERMANY CANCER EARLY DETECTION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 281. GERMANY CANCER EARLY DETECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 282. GERMANY CANCER EARLY DETECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 283. FRANCE CANCER EARLY DETECTION MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 284. FRANCE CANCER EARLY DETECTION MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 285. FRANCE CANCER EARLY DETECTION MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 286. FRANCE CANCER EARLY DETECTION MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 287. FRANCE CANCER EARLY DETECTION MARKET SIZE, BY MODALITY, 2018-2024 (USD MILLION)
TABLE 288. FRANCE CANCER EARLY DETECTION MARKET SIZE, BY MODALITY, 2025-2030 (USD MILLION)
TABLE 289. FRANCE CANCER EARLY DETECTION MARKET SIZE, BY BIOMARKER, 2018-2024 (USD MILLION)
TABLE 290. FRANCE CANCER EARLY DETECTION MARKET SIZE, BY BIOMARKER, 2025-2030 (USD MILLION)
TABLE 291. FRANCE CANCER EARLY DETECTION MARKET SIZE, BY GENETIC BIOMARKER, 2018-2024 (USD MILLION)
TABLE 292. FRANCE CANCER EARLY DETECTION MARKET SIZE, BY GENETIC BIOMARKER, 2025-2030 (USD MILLION)
TABLE 293. FRANCE CANCER EARLY DETECTION MARKET SIZE, BY IMAGING, 2018-2024 (USD MILLION)
TABLE 294. FRANCE CANCER EARLY DETECTION MARKET SIZE, BY IMAGING, 2025-2030 (USD MILLION)
TABLE 295. FRANCE CANCER EARLY DETECTION MARKET SIZE, BY MOLECULAR, 2018-2024 (USD MILLION)
TABLE 296. FRANCE CANCER EARLY DETECTION MARKET SIZE, BY MOLECULAR, 2025-2030 (USD MILLION)
TABLE 297. FRANCE CANCER EARLY DETECTION MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 298. FRANCE CANCER EARLY DETECTION MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 299. FRANCE CANCER EARLY DETECTION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 300. FRANCE CANCER EARLY DETECTION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 301. FRANCE CANCER EARLY DETECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 302. FRANCE CANCER EARLY DETECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 303. RUSSIA CANCER EARLY DETECTION MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 304. RUSSIA CANCER EARLY DETECTION MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 305. RUSSIA CANCER EARLY DETECTION MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 306. RUSSIA CANCER EARLY DETECTION MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 307. RUSSIA CANCER EARLY DETECTION MARKET SIZE, BY MODALITY, 2018-2024 (USD MILLION)
TABLE 308. RUSSIA CANCER EARLY DETECTION MARKET SIZE, BY MODALITY, 2025-2030 (USD MILLION)
TABLE 309. RUSSIA CANCER EARLY DETECTION MARKET SIZE, BY BIOMARKER, 2018-2024 (USD MILLION)
TABLE 310. RUSSIA CANCER EARLY DETECTION MARKET SIZE, BY BIOMARKER, 2025-2030 (USD MILLION)
TABLE 311. RUSSIA CANCER EARLY DETECTION MARKET SIZE, BY GENETIC BIOMARKER, 2018-2024 (USD MILLION)
TABLE 312. RUSSIA CANCER EARLY DETECTION MARKET SIZE, BY GENETIC BIOMARKER, 2025-2030 (USD MILLION)
TABLE 313. RUSSIA CANCER EARLY DETECTION MARKET SIZE, BY IMAGING, 2018-2024 (USD MILLION)
TABLE 314. RUSSIA CANCER EARLY DETECTION MARKET SIZE, BY IMAGING, 2025-2030 (USD MILLION)
TABLE 315. RUSSIA CANCER EARLY DETECTION MARKET SIZE, BY MOLECULAR, 2018-2024 (USD MILLION)
TABLE 316. RUSSIA CANCER EARLY DETECTION MARKET SIZE, BY MOLECULAR, 2025-2030 (USD MILLION)
TABLE 317. RUSSIA CANCER EARLY DETECTION MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 318. RUSSIA CANCER EARLY DETECTION MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 319. RUSSIA CANCER EARLY DETECTION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 320. RUSSIA CANCER EARLY DETECTION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 321. RUSSIA CANCER EARLY DETECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 322. RUSSIA CANCER EARLY DETECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 323. ITALY CANCER EARLY DETECTION MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 324. ITALY CANCER EARLY DETECTION MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 325. ITALY CANCER EARLY DETECTION MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 326. ITALY CANCER EARLY DETECTION MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 327. ITALY CANCER EARLY DETECTION MARKET SIZE, BY MODALITY, 2018-2024 (USD MILLION)
TABLE 328. ITALY CANCER EARLY DETECTION MARKET SIZE, BY MODALITY, 2025-2030 (USD MILLION)
TABLE 329. ITALY CANCER EARLY DETECTION MARKET SIZE, BY BIOMARKER, 2018-2024 (USD MILLION)
TABLE 330. ITALY CANCER EARLY DETECTION MARKET SIZE, BY BIOMARKER, 2025-2030 (USD MILLION)
TABLE 331. ITALY CANCER EARLY DETECTION MARKET SIZE, BY GENETIC BIOMARKER, 2018-2024 (USD MILLION)
TABLE 332. ITALY CANCER EARLY DETECTION MARKET SIZE, BY GENETIC BIOMARKER, 2025-2030 (USD MILLION)
TABLE 333. ITALY CANCER EARLY DETECTION MARKE
Samples
LOADING...
Companies Mentioned
The companies profiled in this Cancer Early Detection Market report include:- F. Hoffmann-La Roche Ltd.
- Thermo Fisher Scientific Inc.
- Abbott Laboratories
- QIAGEN N.V.
- Illumina, Inc.
- Sysmex Corporation
- Becton, Dickinson and Company
- Bio-Rad Laboratories, Inc.
- Guardant Health, Inc.
- Exact Sciences Corporation
